Integrative therapies for managing symptoms in multiple myeloma
Effectiveness and Safety of Integrative Therapies in Multiple Myeloma
This study is testing if combining different treatments can help people with multiple myeloma feel better and improve their quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 300 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Bnai Zion Medical Center Government |
| Locations | 1 site (Haifa) |
| Trial ID | NCT06515249 on ClinicalTrials.gov |
What this trial studies
This study focuses on the use of integrative medicine to address the various symptoms experienced by patients with multiple myeloma, a chronic hematologic malignancy. It aims to improve quality of life by employing both pharmacological and non-pharmacological treatments tailored to the individual needs of patients. Participants will be required to complete monthly questionnaires to assess their symptoms and overall well-being. The study emphasizes the importance of quality-of-life outcomes in the management of this disease.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old who have been diagnosed with multiple myeloma and can communicate in Hebrew, Arabic, or Russian.
Not a fit: Patients under 18 years old, those with severe platelet deficiencies, or individuals with psychiatric disorders that impair their ability to participate may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance the quality of life for patients suffering from multiple myeloma by effectively managing their symptoms.
How similar studies have performed: While integrative approaches in managing chronic conditions have shown promise, this specific study's methodology is relatively novel in the context of multiple myeloma.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age over 18 * Diagnosis of multiple myeloma * Possibility to answer questionnaires once a month in Hebrew, Arabic or Russian * Signing an informed consent form Exclusion Criteria: * Age under 18 years * In patients who will receive acupuncture: platelet level below 20x10\^9/L * In patients who will receive reflexology: deep vein thrombosis in the leg * Hemodynamic instability * Psychiatric disorder impairing competence
Where this trial is running
Haifa
- Bnai Zion Medical Center — Haifa, Israel (Recruiting)
Study contacts
- Principal investigator: Ilana Levy Yurkovski, MD — Bnai Zion Medical Center, Haifa, Israel
- Study coordinator: Ilana Levy Yurkovski, MD
- Email: ilana.levy@b-zion.org.il
- Phone: +972525086128
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.